Selling a Dental Practice Business in Raleigh, NC — Buyers, Multiples & What to Expect

A general dental practice in Raleigh, NC is selling at 4.5x to 7.5x EBITDA at the DSO platform level and 2.5x to 4.5x EBITDA for private associate-buyer transactions. Raleigh is, in my view, the single most competitive Southeast dental market in 2026 — the demographic engine and the buyer bench are both unusually deep.

What Makes the Raleigh Dental Market Different?

Three forces drive Raleigh’s outperformance versus other Carolina markets. First, the Research Triangle employer base — Duke Health, IBM, SAS Institute, Cisco, Fidelity, Red Hat, and the state government — produces a young, professional, employer-insured patient population that buyers underwrite at a premium. Wake County household incomes run materially above the North Carolina average. Second, in-migration into the Triangle has been one of the fastest in the United States for the better part of a decade, which keeps new-patient flow strong even as competition densifies. Third, the dental buyer landscape in Raleigh is genuinely crowded: Heartland Dental, Pacific Dental Services, Aspen Dental, Mortenson Dental Partners, and Riccobene Associates Family Dentistry all have meaningful local platforms, and PE-backed regional players like MB2 Dental, North American Dental Group, Imagen Dental Partners, and Smile Brands are actively running tuck-in pipelines. That depth means a well-prepared Raleigh practice will reliably draw six to ten serious indications of interest. For more on the metro’s broader transaction landscape, see our Raleigh sell-your-business hub.

Buyer Demand for Raleigh Dental Practices

Demand sorts cleanly by EBITDA scale. Above $1M of adjusted EBITDA, you’re in the platform sweet spot — Heartland, Aspen, PDS, and Smile Brands compete aggressively for multi-doctor general practices. The $400K–$1M EBITDA range is where regional and PE-backed platforms (Mortenson, Riccobene, MB2 Dental, NADG, Imagen Dental Partners) live, and Raleigh sees especially strong tuck-in interest because every major platform already operates locations in the metro. For specialty practices, category platforms like Smile Doctors (orthodontics), U.S. Oral Surgery Management (oral surgery), and Specialty Dental Brands (multi-specialty) compete with the general DSOs and consistently push specialty multiples toward the high end of the range. Below $400K of EBITDA the realistic buyer pool narrows to associate dentists, search-fund operators, and small regional groups, and pricing reverts to the collections rule of thumb. Multi-location groups under one ownership umbrella attract the strongest premium because platform back-office and procurement synergies underwrite incremental value immediately.

What Dental Practices Sell For in Raleigh

Real Raleigh transaction multiples have held remarkably steady over the last 18 months. General practices sold to DSO platforms cleared 4.5x to 7.5x adjusted EBITDA, with the top of the range reserved for $1M+ EBITDA practices with multi-doctor staffing, modern technology (CBCT, intraoral scanners, paperless charting), strong recall (75%+), and a 10-year lease. Solo associate-buyer transactions cleared 2.5x to 4.5x EBITDA, equivalent to 60%–85% of TTM collections. Raleigh orthodontic practices have transacted up to 9.0x EBITDA on production above $2M with a multi-year doctor work-back. Oral surgery trades at 6.5x to 9.0x EBITDA; pediatric at 5.5x–8.0x; endodontics at 5.0x–7.5x. The two recurring valuation drivers I see in Raleigh deals are seller post-close commitment (two or more clinical work-back years routinely adds $300K–$700K of enterprise value) and the practice’s share of revenue from clear aligners, implants, and in-house endodontics — buyers reward production diversification. The valuation framework mirrors what we cover on our dental-practices hub.

What Raleigh Dental Practice Owners Need to Know Before Selling

Three issues recur in Raleigh diligence. First, payor concentration: even though the Triangle employer base is diverse, individual practices often concentrate in two or three plans tied to a single employer cluster. Buyers want to see no single payor above 25% of collections. Second, the Raleigh clinical labor market is tighter than at any point I’ve seen in fifteen years. Hygienist turnover above 30% on the year materially compresses multiples — buyers project recall declines and price the risk in. Third, lease structure: medical-office vacancy in North Hills, Brier Creek, and Cary is low and landlord leverage during assignment is real. A 10-year option negotiated before launch is now standard advice. The fourth thing I’d flag — and it’s genuinely Raleigh-specific — is associate compensation benchmarking. The Triangle’s associate market is competitive, and sellers who underpay will see it surface as a buyer add-back in diligence that compresses adjusted EBITDA. Pay your associates market before you sell, not as a post-close fix.

I closed a Cary general practice last spring at the top of the range — 7.4x EBITDA — and the deciding factor wasn’t the production number. It was that the seller had spent two years building a second-doctor model with two associates already paying their own way at market comp. The platform buyer underwrote zero key-person risk because the practice didn’t depend on the seller. That’s the Raleigh playbook: build a practice that doesn’t need you, then sell it.